Gossamer Bio (GOSS) said Wednesday that about $181.1 million worth of its existing convertible notes was validly tendered in a previously announced exchange offer.
The offer involved exchanging its 5.00% convertible senior notes due 2027 for a pro rata portion of up to $72.0 million worth of its new 7.50% convertible senior secured first lien notes due 2030, and up to 317.6 million shares of its common stock.
Gossamer also said it is offering prefunded warrants for shareholders who own more than 9.99% of the outstanding shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments